$24.200
+1.120 (+4.63%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
Attovia Therapeutics Inc 株は買うべき？
Attovia Therapeutics, Inc. is a good buy right now due to its recent successful IPO that raised approximately $289 million, reflecting strong market interest. The stock is currently priced at $20.70, which is significantly lower than the analyst price target of $25, suggesting a potential upside of about 20.5%. Additionally, the forward P/E ratio of 4.81 indicates that the stock may be undervalued compared to future earnings expectations. However, the main risk is the negative net income reported for Q1 2026, which stands at -18.66 million USD, indicating ongoing financial challenges.
ATTO の株価は Thursday に $24.20 で引け、その前に上昇 +4.63%
Attovia Therapeutics Inc (ATTO) last closed at $24.2, gaining +4.63%. These facts feed the 1-day and 1-week ATTO price prediction above.
予想の要因
Attovia Therapeutics Inc（ATTO）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Seasonality
Bullish
ATTO の季節性分析
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。